Factor | Detalis | cases | controls | Statistics |
Group | 72 (44.4%) | 90 (55.6%) | ||
Sex | F | 38 (52.8%) | 42 (46.7%) | OR=1.28 [0.69, 2.38], phi=0.06 (p=0.527) |
M | 34 (47.2%) | 48 (53.3%) | ||
Age (years) | μ ±DS | 11.93 ±4.27 | 10.19 ±5.08 | MW: p=0.037 |
Age at onset (years) | μ ±DS | 6.84 ±3.97 | ||
Body mass index (kg/m²) | μ ±DS | 18.96 ±3.37 | 17.32 ±4.06 | MW: p=0.001 |
Weight (kg) | μ ±DS | 45.15 ±17.8 | 37.00 ±19.8 | MW: p=0.004 |
HbA1c (%) | μ ±DS | 8.81 ±1.79 | 4.81 ±0.451 | MW: p<0.001 |
Insulin intake (IU/kg/day) | μ ±DS | 0.949 ±0.271 | ||
Injections/day n (%) | 4 | 40 (55.6%) | 0 | V=NaN (p=1.000) |
5 | 25 (34.7%) | 0 | ||
insulin pump | 7 (9.7%) | 0 | ||
Neuropathy n (%) | 24 (33.3%) | 0 | OR=91.43 [5.44, 1 536.40], phi=0.47 (p<0.001) | |
Nephropathy n (%) | 6 (8.6%) | 0 | OR=18.24 [1.01, 329.56], phi=0.22 (p=0.006) | |
Retinopathy, n (%) | 2 (2.8%) | 0 | OR=6.42 [0.30, 135.84], phi=0.12 (p=0.196) | |
Other complications* | 59 (81.9%) | 0 | OR=797.74 [46.54, Inf], phi=0.85 (p<0.001) | |
Systolic blood pressure (mmHg) | μ ±DS | 100.21 ±11.9 | 101.50 ±12.9 | MW: p=0.575 |
Diastolic blood pressure (mmHg) | μ ±DS | 54.65 ±10.7 | 56.83 ±9.32 | MW: p=0.219 |
Adiponectin (μg/L) | μ ±DS | 14.07 ±4.69 | ||
TNF-alfa (pg/mL) | μ ±DS | 11.09 ±4.21 | ||
Alfa 1AT | μ ±DS | 133.50 ±18.2 | 155.07 ±28.3 | MW: p=0.002 |
Cholesterol (mg/dL) | μ ±DS | 169.57 ±41.0 | 153.19 ±22.3 | MW: p=0.008 |
Triglycerides (mg/dL) | μ ±DS | 85.32 ±48.5 | 72.43 ±29.0 | MW: p=0.132 |
HDL (mg/dL) | μ ±DS | 54.47 ±11.3 | 53.40 ±9.76 | MW: p=0.693 |
μ ±DS = Mean (standard deviation); M (min:max) = Median (min:max); MW = Mann-WhitneyTest; OR/RR = odds-ratio / risc-ratio [95% CI] and p value from Fisher test); V = Cramer V (p value from Chi² test); | ||||